ANG Lifesciences India has informed that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended form time to time read with Company’s Code of conduct to regulate, monitor and report the trading of equity shares. The trading window for dealing in the securities of the Company shall remain closed from 01st July, 2025 for the insider, designated persons of the company and their immediate relatives, till the end of 48 hours after declaration of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June, 2025. The date of Board Meeting for consideration of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2025 shall be intimated separately.
The above information is a part of company’s filings submitted to BSE.
